Determinants of cognitive dysfunction in adults with sickle cell-related stroke or suspected neurological morbidity.
Despina MessimerisHugo BismuthCorentin ProvostClémentine EmaerNicolas MéléRobert M KitengeJean-Benoit ArletLaure JosephBrigitte RanquePablo BartolucciPauline NarmeDavid CalvetPublished in: Blood advances (2024)
The prognosis of sickle cell disease (SCD) in adults is determined primarily by damage to targeted organs such as the brain. Cognitive dysfunction in SCD is a common chronic neurological manifestation, but studies remain mostly descriptive in adults. The objective of this study was to better characterize the cognitive profile and the association between cognitive dysfunction and brain lesions. We included adult patients with SCD referred for a neurological assessment. An adapted battery of neuropsychological tests was used to assess cognitive deficits. Brain or arterial abnormalities were assessed using brain magnetic resonance imaging/magnetic resonance angiography and a cervical and transcranial Doppler ultrasound. The cognitive profile of 96 patients was characterized by deficits in processing speed (58%), short-term memory (34%), and working memory (24%). Brain infarcts were found in 56% of patients and intracranial vasculopathy in 49%. Twenty percent of patients had no brain abnormalities. Processing speed dysfunction was associated with territorial infarcts (odds ratio [OR], 3.1; P = .03) and education outside of France (OR, 4.7; P = .02). Short-term memory dysfunction was associated with territorial infarcts (OR, 3.4; P = .01) and a low educational level (OR, 8.2; P = .01). Working memory dysfunction was associated with a low educational level (OR, 4.3; P = .05) and vasculopathy (OR, 3.7; P = .03). Cognitive dysfunction appears to be a hallmark sign of SCD, particularly for adults with sickle cell-related stroke or suspected neurological morbidity. Assessment of such dysfunction could be used in longitudinal follow-up and clinical trials.
Keyphrases
- working memory
- end stage renal disease
- magnetic resonance imaging
- cerebral ischemia
- resting state
- ejection fraction
- magnetic resonance
- white matter
- newly diagnosed
- chronic kidney disease
- clinical trial
- functional connectivity
- prognostic factors
- sickle cell disease
- healthcare
- computed tomography
- atrial fibrillation
- attention deficit hyperactivity disorder
- transcranial direct current stimulation
- cross sectional
- optical coherence tomography
- multiple sclerosis
- blood flow
- brain injury
- subarachnoid hemorrhage
- patient reported
- cancer therapy
- open label
- drug induced
- case control